BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9218505)

  • 1. Role of nitric oxide in obesity-induced beta cell disease.
    Shimabukuro M; Ohneda M; Lee Y; Unger RH
    J Clin Invest; 1997 Jul; 100(2):290-5. PubMed ID: 9218505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.
    Shimabukuro M; Zhou YT; Levi M; Unger RH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2498-502. PubMed ID: 9482914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes.
    Hirose H; Lee YH; Inman LR; Nagasawa Y; Johnson JH; Unger RH
    J Biol Chem; 1996 Mar; 271(10):5633-7. PubMed ID: 8621426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.
    Unger RH
    Diabetes; 1995 Aug; 44(8):863-70. PubMed ID: 7621989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence.
    Ohneda M; Inman LR; Unger RH
    Diabetologia; 1995 Feb; 38(2):173-9. PubMed ID: 7713311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes.
    Zhou YT; Shimabukuro M; Lee Y; Koyama K; Higa M; Ferguson T; Unger RH
    Diabetes; 1998 Dec; 47(12):1904-8. PubMed ID: 9836522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
    Zhou YP; Cockburn BN; Pugh W; Polonsky KS
    Metabolism; 1999 Jul; 48(7):857-64. PubMed ID: 10421226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.
    Lee Y; Hirose H; Zhou YT; Esser V; McGarry JD; Unger RH
    Diabetes; 1997 Mar; 46(3):408-13. PubMed ID: 9032096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of alogliptin and pioglitazone on lipid metabolism in islets of prediabetic and diabetic Zucker Diabetic Fatty rats.
    Cai Y; Lydic TA; Turkette T; Reid GE; Olson LK
    Biochem Pharmacol; 2015 May; 95(1):46-57. PubMed ID: 25801003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation.
    Bollheimer LC; Skelly RH; Chester MW; McGarry JD; Rhodes CJ
    J Clin Invest; 1998 Mar; 101(5):1094-101. PubMed ID: 9486980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
    Goh TT; Mason TM; Gupta N; So A; Lam TK; Lam L; Lewis GF; Mari A; Giacca A
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide.
    Weksler-Zangen S; Aharon-Hananel G; Mantzur C; Aouizerat T; Gurgul-Convey E; Raz I; Saada A
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E648-57. PubMed ID: 24425765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.
    Lee Y; Hirose H; Ohneda M; Johnson JH; McGarry JD; Unger RH
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10878-82. PubMed ID: 7971976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-GLUT-2 defects in beta-cells of non-insulin-dependent diabetic obese rats.
    Ohneda M; Johnson JH; Lee YH; Nagasawa Y; Unger RH
    Am J Physiol; 1994 Dec; 267(6 Pt 1):E968-74. PubMed ID: 7810642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes.
    Johnson JH; Ogawa A; Chen L; Orci L; Newgard CB; Alam T; Unger RH
    Science; 1990 Oct; 250(4980):546-9. PubMed ID: 2237405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats.
    Harmon JS; Gleason CE; Tanaka Y; Poitout V; Robertson RP
    Diabetes; 2001 Nov; 50(11):2481-6. PubMed ID: 11679425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat.
    Sturis J; Pugh WL; Tang J; Ostrega DM; Polonsky JS; Polonsky KS
    Am J Physiol; 1994 Aug; 267(2 Pt 1):E250-9. PubMed ID: 8074204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.